| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/16/2013 | US8487001 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486955 Anti-cancer cyclopenta [g] quinazoline compounds |
| 07/16/2013 | US8486894 Synthetic peptide amides and dimeric forms thereof |
| 07/16/2013 | US8486892 Blood coagulation factor inhibitors |
| 07/16/2013 | US8486891 Nasal calcitonin formulations containing chlorobutanol |
| 07/16/2013 | US8486890 Amylin derivatives |
| 07/16/2013 | US8486889 Composition and method for the treatment and prevention of endothelial dysfunction |
| 07/16/2013 | US8486888 Methods for use of branched amino acids |
| 07/16/2013 | US8486887 Enhancement of Bacillus thuringiensis Cry protein toxicities to coleopterans, and novel insect cadherin fragments |
| 07/16/2013 | US8486886 Botulinum toxin treatments |
| 07/16/2013 | US8486885 β-arrestin effectors and compositions and methods of use thereof |
| 07/16/2013 | US8486678 Pharmaceutical compositions for the treatment of virus infection |
| 07/16/2013 | US8486467 Dermal filler and method of using same |
| 07/16/2013 | US8486455 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/16/2013 | US8486438 Methods for progenitor cell recruitment and isolation |
| 07/16/2013 | US8486421 Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use |
| 07/16/2013 | US8486416 Use of SDF-1 to improve ischemic myocardial function |
| 07/16/2013 | US8486413 Immunological compositions as cancer therapeutics |
| 07/16/2013 | US8486412 Immunity to folate receptors |
| 07/16/2013 | US8486410 RLIP76 liposomes for protection against irradiation |
| 07/16/2013 | US8486402 Anti-CD98 antibody |
| 07/16/2013 | US8486401 Monoclonal antibodies binding to TrkA and acting as NGF-antagonist molecules and their use for treating pain induced by NGF |
| 07/16/2013 | US8486400 Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling |
| 07/16/2013 | US8486399 Methods and compositions for increasing arylsulfatase A activity in the CNS |
| 07/16/2013 | US8486396 Compositions and methods for diagnosing and treating an inflammation |
| 07/16/2013 | US8486391 Cancer treatment kits using antibodies to aminophospholipids |
| 07/16/2013 | US8486390 Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same |
| 07/16/2013 | US8486389 Compositions and methods for treating or preventing oxalate-related disease |
| 07/16/2013 | US8486388 Protein formulation |
| 07/16/2013 | US8486387 Modified two-component gelation systems, methods of use and methods of manufacture |
| 07/16/2013 | US8486386 Modified two-component gelation systems, methods of use and methods of manufacture |
| 07/16/2013 | US8486385 Methods for therapy of neurodegenerative disease of the brain |
| 07/16/2013 | US8486384 Lipidized interferon and methods of treating viral hepatitis |
| 07/16/2013 | US8486383 Method of treating pulmonary disease with interferons |
| 07/16/2013 | US8486382 Method for treating cervical cancer |
| 07/16/2013 | CA2738715C Highly concentrated drug particles, formulations, suspensions and uses thereof |
| 07/16/2013 | CA2641830C Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders |
| 07/16/2013 | CA2591786C Prevention of thrombus formation and/or stabilization |
| 07/16/2013 | CA2535029C Pharmaceutical compositions and methods for accelerating wound healing |
| 07/16/2013 | CA2533522C Amino acid-substituted coagulation factor v |
| 07/16/2013 | CA2526007C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 07/16/2013 | CA2516834C Polypeptides and methods for making the same |
| 07/16/2013 | CA2512138C Kim-1 antagonists and use to modulate immune system |
| 07/16/2013 | CA2502928C Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 07/16/2013 | CA2496215C Template-fixed peptidomimetics with antibacterial activity |
| 07/16/2013 | CA2490542C Fas peptide mimetics and uses thereof |
| 07/16/2013 | CA2483980C Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 07/16/2013 | CA2478629C Method and apparatus for producing dry particles |
| 07/16/2013 | CA2448348C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/16/2013 | CA2425486C Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 07/16/2013 | CA2395406C Method for treating inflammation |
| 07/16/2013 | CA2384948C Therapies for chronic renal failure using one or more integrin antagonists |
| 07/16/2013 | CA2358684C Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/16/2013 | CA2350334C New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs |
| 07/16/2013 | CA2330231C Composition and method for modulating dendritic cell-t cell interaction |
| 07/16/2013 | CA2289742C Method for generating activated t-cells and antigen-pulsed antigen-presenting cells |
| 07/16/2013 | CA2253441C Glycoprotein hormone superagonists |
| 07/16/2013 | CA2226624C Methods for treatment of allergic asthma |
| 07/12/2013 | WO2012094495A2 Clip modulation for the treatment of mucosal diseases |
| 07/11/2013 | WO2013103981A1 Compositions and methods of use of fndc5 polypeptides |
| 07/11/2013 | WO2013103972A1 Treatment of frailty syndrome and symptoms thereof |
| 07/11/2013 | WO2013103966A1 Methods for the treatment of multiple sclerosis and other demyelinating disorders |
| 07/11/2013 | WO2013103964A1 Methods and compositions for treating proteinopathies |
| 07/11/2013 | WO2013103936A1 Method of treating pain by administration of nerve growth factor |
| 07/11/2013 | WO2013103840A1 Anti-cancer composition and method utilizing 3-bp and liposomal reduced glutathione |
| 07/11/2013 | WO2013103811A2 Slit-robo signaling for diagnosis and treatment of kidney disease |
| 07/11/2013 | WO2013103792A2 Method of treating cancer by administration of low levels of heat shock protein 70 (hsp70) |
| 07/11/2013 | WO2013103780A1 Compositions and methods to boost endogenous ros production from bacteria |
| 07/11/2013 | WO2013103746A1 Methods of treating behavioral symptoms of neurological and mental disorders |
| 07/11/2013 | WO2013103688A1 Human soluble receptors for advanced glycation end products (srage), methods of preparing human srage, and treatment methods using srage |
| 07/11/2013 | WO2013103658A1 Native and agonist ctl epitopes of the muc1 tumor antigen |
| 07/11/2013 | WO2013103628A1 Peptides and methods for detecting mpo-anca |
| 07/11/2013 | WO2013103424A2 Silk-based multifunctional biomedical platform |
| 07/11/2013 | WO2013103248A1 Myostatin inhibitor comprising extracellular water-soluble domains of dlk1 as active ingredient |
| 07/11/2013 | WO2013102921A2 Hcg - newer treatment modality for type 2 diabetes mellitus (t2dm) |
| 07/11/2013 | WO2013102899A1 Methods and compositions for treating diabetes |
| 07/11/2013 | WO2013102641A1 Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers |
| 07/11/2013 | WO2013102290A1 Method for specifically recognizing dna containing 5-methylated cytosine |
| 07/11/2013 | WO2013102289A1 Specific binding and targeting method for dna-rna heteroduplex |
| 07/11/2013 | WO2013102265A1 Compositions and methods for treating multiple sclerosis |
| 07/11/2013 | WO2013102264A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 07/11/2013 | WO2013066471A3 Methods and compositions for preventing and treating an anthrax toxin mediated condition in a subject |
| 07/11/2013 | WO2013063155A3 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| 07/11/2013 | WO2013062959A3 Continuous subcutaneous administration of interferon-alpha to hepatitis b infected patients |
| 07/11/2013 | WO2013049149A3 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 07/11/2013 | WO2013043033A3 Method for extracting and checking a dialysed extract of leukocytes from shark spleen, in order to obtain a transfer factor with increased potential, specifically designed to be used as an adjuvant for increasing the potential of viral vaccines |
| 07/11/2013 | WO2013042943A3 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand |
| 07/11/2013 | WO2013036973A3 Methods and compositions for controlling assembly of viral proteins |
| 07/11/2013 | WO2013030838A3 Dendrimer-lyotropic liquid crystal (llc) systems |
| 07/11/2013 | WO2013020136A3 Treatment of traumatic brain injury |
| 07/11/2013 | WO2013019445A3 Anti-angiogenic peptides and uses thereof |
| 07/11/2013 | WO2013013105A3 Compositions and methods for re-programming cells without genetic modification for repairing cartilage damage |
| 07/11/2013 | WO2013009943A3 Micro-utrophin polypeptides and methods |
| 07/11/2013 | WO2012164398A3 Modulation of the ubiquitin-proteasome system (ups) |
| 07/11/2013 | WO2012162534A3 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use |
| 07/11/2013 | WO2012061045A3 Methods and compositions for preserving retinal ganglion cells |
| 07/11/2013 | WO2011163652A3 Treatment of sanfilippo syndrome type b |
| 07/11/2013 | WO2011163012A3 Amide based glucagon superfamily peptide prodrugs |
| 07/11/2013 | US20130178513 Modulation of eif4e expression |